Marie‐Claude Jaurand

FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder.

Ashraf Bakkar, Hervé Wallerand, François Radvanyi et al. · PubMed · 2003 · 272 citations

Medicine, Genetics, Oncology +15

Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications

Yuna Blum, Clément Meiller, Lisa Quetel et al. · Nature Communications · 2019 · 206 citations · Full text

Medicine, Oncology, Pathology +17

Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition

Aurélien de Reyniès, Marie‐Claude Jaurand, Annie Renier et al. · Clinical Cancer Research · 2014 · 149 citations · Full text

Medicine, Oncology, Pathology +17

Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?

Marie‐Claude Jaurand, Annie Renier, Julien Daubriac · Particle and Fibre Toxicology · 2009 · 144 citations · Full text

Natural Sciences, Oncology, Toxicology +13

Role of Pleural Mesothelial Cells in the Production of the Submesothelial Connective Tissue Matrix of Lung

Stephen I. Rennard, Marie‐Claude Jaurand, J. Bignon et al. · American Review of Respiratory Disease · 1984 · 137 citations

Life Sciences, Cell Biology, Physiology +16